166 related articles for article (PubMed ID: 17598371)
1. Human serum paraoxonase concentration predicts cardiovascular mortality in hemodialysis patients.
Ikeda Y; Suehiro T; Itahara T; Inui Y; Chikazawa H; Inoue M; Arii K; Hashimoto K
Clin Nephrol; 2007 Jun; 67(6):358-65. PubMed ID: 17598371
[TBL] [Abstract][Full Text] [Related]
2. Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes.
Ikeda Y; Inoue M; Suehiro T; Arii K; Kumon Y; Hashimoto K
Acta Diabetol; 2009 Sep; 46(3):239-42. PubMed ID: 18830558
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.
Zhang B; Eto S; Fan P; Bian C; Shimoji E; Saito T; Saku K
Clin Nephrol; 2003 Oct; 60(4):257-65. PubMed ID: 14579940
[TBL] [Abstract][Full Text] [Related]
4. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.
Sztanek F; Seres I; Harangi M; Lőcsey L; Padra J; Paragh GJ; Asztalos L; Paragh G
Nephrol Dial Transplant; 2012 Jul; 27(7):2866-72. PubMed ID: 22247228
[TBL] [Abstract][Full Text] [Related]
5. Serum Endocan Levels are Associated With Paraoxonase 1 Concentration in Patients With Chronic Kidney Disease.
Samouilidou E; Bountou E; Papandroulaki F; Papamanolis M; Papakostas D; Grapsa E
Ther Apher Dial; 2018 Aug; 22(4):325-331. PubMed ID: 29368426
[TBL] [Abstract][Full Text] [Related]
6. Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease.
Samouilidou E; Kostopoulos V; Liaouri A; Kioussi E; Vassiliou K; Bountou E; Grapsa E
Ren Fail; 2016 Nov; 38(10):1601-1606. PubMed ID: 26888625
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis.
Kannampuzha J; Darling PB; Maguire GF; Donnelly S; McFarlane P; Chan CT; Connelly PW
Clin Nephrol; 2010 Feb; 73(2):131-8. PubMed ID: 20129020
[TBL] [Abstract][Full Text] [Related]
8. HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism.
Schiavon R; Battaglia P; De Fanti E; Fasolin A; Biasioli S; Targa L; Guidi G
Clin Chim Acta; 2002 Oct; 324(1-2):39-44. PubMed ID: 12204423
[TBL] [Abstract][Full Text] [Related]
9. Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients.
Locsey L; Seres I; Sztanek F; Harangi M; Padra J; Kovacs D; Fedor R; Asztalos L; Paragh G
Transplant Proc; 2013; 45(10):3685-7. PubMed ID: 24314997
[TBL] [Abstract][Full Text] [Related]
10. Association of plasma macrophage colony-stimulating factor with cardiovascular morbidity and all-cause mortality in chronic hemodialysis patients.
Deng X; Yang Q; Wang Y; Yang Y; Pei G; Zhu H; Wu J; Wang M; Zhao Z; Xu H; Zhou C; Guo Y; Yao Y; Zhang Z; Liao W; Zeng R
BMC Nephrol; 2019 Aug; 20(1):321. PubMed ID: 31419967
[TBL] [Abstract][Full Text] [Related]
11. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
12. Main determinants of PON1 activity in hemodialysis patients.
Ribeiro S; do Sameiro Faria M; Mascarenhas-Melo F; Freitas I; Mendonça MI; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Belo L; Costa E; Reis F; Santos-Silva A
Am J Nephrol; 2012; 36(4):317-23. PubMed ID: 23007074
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients.
Saeed SA; Elsharkawy M; Elsaeed K; Fooda O
Hemodial Int; 2008 Oct; 12(4):471-9. PubMed ID: 19090870
[TBL] [Abstract][Full Text] [Related]
14. Effect of nutritional status on human paraoxonase-1 activity in patients with chronic kidney disease.
Sztanek F; Seres I; Harangi M; Lőcsey L; Koncsos P; Paragh G
Kidney Blood Press Res; 2012; 36(1):310-9. PubMed ID: 23235285
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients.
Grzegorzewska AE; Adamska P; Iwańczyk-Skalska E; Ostromecka K; Niepolski L; Marcinkowski W; Mostowska A; Warchoł W; Żaba C; Jagodziński PP
Sci Rep; 2021 Mar; 11(1):6773. PubMed ID: 33762698
[TBL] [Abstract][Full Text] [Related]
16. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population.
Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J
Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660
[TBL] [Abstract][Full Text] [Related]
17. Hyperleptinemia is not responsible for decreased paraoxonase activity in hemodialysis patients.
Varga Z; Paragh G; Seres I; Kakuk G; Karanyi Z; Karpati I; Matyus J; Csongradi E; Juhasz A; Balla J; Bajnok L
Nephron Clin Pract; 2006; 103(3):c114-20. PubMed ID: 16534235
[TBL] [Abstract][Full Text] [Related]
18. Serum paraoxonase (PON1) concentration in patients undergoing hemodialysis.
Suehiro T; Ikeda Y; Shiinoki T; Inoue M; Kumon Y; Itahara T; Hashimoto K
J Atheroscler Thromb; 2002; 9(3):133-8. PubMed ID: 12226554
[TBL] [Abstract][Full Text] [Related]
19. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study.
Kresanov P; Vasankari T; Ahotupa M; Kaikkonen J; Hutri-Kähönen N; Juonala M; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT
Atherosclerosis; 2015 Aug; 241(2):502-6. PubMed ID: 26091975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
